Sveriges mest populära poddar

GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)

8 min•16 juni 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

See omnystudio.com/listener for privacy information.

Fler avsnitt

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

26 sep.48 min

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

25 sep.18 min

Meta Introduces Palm-Sized Device to Use Muse AI

24 sep.19 min

Disney+ Price to Jump 13% to $21.49 Per Month

23 sep.22 min

Meta’s New Muse AI App Makes Shopping Easier

22 sep.17 min

Paramount to Settle Lawsuits Against WBD Deal

21 sep.19 min

The Bank of Mom & Dad; College Sports Going Pro & The Return of the Suit

19 sep.44 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.